Apocynin-Treatment Reverses Hyperoxaluria Induced Changes in NADPH Oxidase System Expression in Rat Kidneys: A Transcriptional Study

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Joshi, Sunil ^a   Saylor, Benjamin T ^b   Wang, Wei ^a   Peck, Ammon B ^a,b,c   Khan, Saeed R ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

^c University of Florida College of Veterinary Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR; APOCYNIN; DIACYLGLYCEROL; HYDROGEN PEROXIDE; OXALIC ACID; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RNA; TRANSCRIPTOME;

ADRENAL MEDULLA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CRYSTALLIZATION; DIET; DOWN REGULATION; ENZYME ACTIVATION; GENE; GENE CLUSTER; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HYPEROXALURIA; IMMUNOHISTOCHEMISTRY; KIDNEY; MALE; NADPH OXIDASE GENE; NEUTROPHIL; NONHUMAN; P21RAC GENE; PROTEIN MICROARRAY; PROTEIN PROTEIN INTERACTION; RAP1A GENE; RAT; RNA ANALYSIS; SIGNAL TRANSDUCTION; UPREGULATION;

ACETOPHENONES; ANIMALS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HYPEROXALURIA; KIDNEY; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; NADPH OXIDASE; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84867605833     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047738     Document Type: Article

References (67)

1. James LF, (1972) Oxalate toxicosis. Clin Toxicol 5: 231-243.
2. Williams HE, Wandzilak TR, (1989) Oxalate synthesis, transport and the hyperoxaluric syndromes. J Urol 141: 742-749.
3. Williams HE, Smith LH, (1968) Disorders of oxalate metabolism. Am J Med 45: 715-735.
4. Lindsjo M, Danielson BG, Fellstrom B, Ljunghall S, (1989) Intestinal oxalate and calcium absorption in recurrent renal stone formers and healthy subjects. Scand J Urol Nephrol 23: 55-59.
5. Menon M, Mahle CJ, (1982) Oxalate metabolism and renal calculi. J Urol 127: 148-151.
6. Hylander E, Jarnum S, Jensen HJ, Thale M, (1978) Enteric hyperoxaluria: dependence on small intestinal resection, colectomy, and steatorrhoea in chronic inflammatory bowel disease. Scand J Gastroenterol 13: 577-588.
7. Binder HJ, (1974) Intestinal oxalate absorption. Gastroenterology 67: 441-446.
8. Dobbins JW, Binder HJ, (1977) Importance of the colon in enteric hyperoxaluria. N Engl J Med 296: 298-301.
9. McConnell N, Campbell S, Gillanders I, Rolton H, Danesh B, (2002) Risk factors for developing renal stones in inflammatory bowel disease. BJU Int 89: 835-841.
10. Worcester EM, (2002) Stones from bowel disease. Endocrinol Metab Clin North Am 31: 979-999.
11. Koul H, Kennington L, Honeyman T, Jonassen J, Menon M, et al. (1996) Activation of c-myc gene mediates the mitogenic effects of oxalate in LLC-PK1 cells, a line of renal epithelial cells. Kidney Int 50: 1525-1530.
12. Koul S, Huang M, Bhat S, Maroni P, Meacham RB, et al. (2008) Oxalate exposure provokes HSP 70 response in LLC-PK1 cells, a line of renal epithelial cells: protective role of HSP 70 against oxalate toxicity. Urol Res 36: 1-10.
13. Koul HK, Menon M, Chaturvedi LS, Koul S, Sekhon A, et al. (2002) COM crystals activate the p38 mitogen-activated protein kinase signal transduction pathway in renal epithelial cells. J Biol Chem 277: 36845-36852.
14. Khan SR, (2006) Renal tubular damage/dysfunction: key to the formation of kidney stones. Urol Res 34: 86-91.
15. Khan SR, Glenton PA, Byer KJ, (2006) Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-L-proline. Kidney Int 70: 914-923.
16. Khan SR, (1995) Calcium oxalate crystal interaction with renal tubular epithelium, mechanism of crystal adhesion and its impact on stone development. Urol Res 23: 71-79.
17. Khan SR, (1997) Animal models of kidney stone formation: an analysis. World J Urol 15: 236-243.
18. Huang HS, Ma MC, Chen J, Chen CF, (2002) Changes in the oxidant-antioxidant balance in the kidney of rats with nephrolithiasis induced by ethylene glycol. J Urol 167: 2584-2593.
19. Huang HS, Chen J, Chen CF, Ma MC, (2006) Vitamin E attenuates crystal formation in rat kidneys: roles of renal tubular cell death and crystallization inhibitors. Kidney Int 70: 699-710.
20. Thamilselvan S, Hackett RL, Khan SR, (1997) Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis. J Urol 157: 1059-1063.
21. Thamilselvan S, Menon M, (2005) Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status. BJU Int 96: 117-126.
22. Khan SR, Kok DJ, (2004) Modulators of urinary stone formation. Front Biosci 9: 1450-1482.
23. Khan SR, (2005) Hyperoxaluria-induced oxidative stress and antioxidants for renal protection. Urol Res 33: 349-357.
24. Khan SR, (2004) Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies. Clin Exp Nephrol 8: 75-88.
25. Khan SR, Khan A, Byer KJ, (2011) Temporal changes in the expression of mRNA of NADPH oxidase subunits in renal epithelial cells exposed to oxalate or calcium oxalate crystals. Nephrol Dial Transplant 26: 1778-1785.
26. Khan SR, Glenton PA, Byer KJ, (2006) Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-L-proline. Kidney Int 70: 914-923.
27. Umekawa T, Byer K, Uemura H, Khan SR, (2005) Diphenyleneiodium (DPI) reduces oxalate ion- and calcium oxalate monohydrate and brushite crystal-induced upregulation of MCP-1 in NRK 52E cells. Nephrol Dial Transplant 20: 870-878.
28. Umekawa T, Chegini N, Khan SR, (2003) Increased expression of monocyte chemoattractant protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals. Nephrol Dial Transplant 18: 664-669.
29. Umekawa T, Iguchi M, Uemura H, Khan SR, (2006) Oxalate ions and calcium oxalate crystal-induced up-regulation of osteopontin and monocyte chemoattractant protein-1 in renal fibroblasts. BJU Int 98: 656-660.
30. Umekawa T, Tsuji H, Uemura H, Khan SR (2009) Superoxide from NADPH oxidase as second messenger for the expression of osteopontin and monocyte chemoattractant protein-1 in renal epithelial cells exposed to calcium oxalate crystals. BJU Int.
31. Zuo J, Khan A, Glenton PA, Khan SR, (2011) Effect of NADPH oxidase inhibition on the expression of kidney injury molecule and calcium oxalate crystal deposition in hydroxy-L-proline-induced hyperoxaluria in the male Sprague-Dawley rats. Nephrol Dial Transplant 26: 1785-1796.
32. da Huang W, Sherman BT, Lempicki RA, (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13.
33. da Huang W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
34. Huang HS, Ma MC, Chen CF, Chen J, (2003) Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones. Urology 62: 1123-1128.
35. Morena M, Cristol JP, Senecal L, Leray-Moragues H, Krieter D, et al. (2002) Oxidative stress in hemodialysis patients: is NADPH oxidase complex the culprit? Kidney Int Suppl: 109-114.
36. Sumimoto H, Miyano K, Takeya R, (2005) Molecular composition and regulation of the Nox family NAD(P)H oxidases. Biochem Biophys Res Commun 338: 677-686.
37. Gao B, Yasui T, Lu X, Zhou H, Liu J, et al. (2010) Matrix Gla protein expression in NRK-52E cells exposed to oxalate and calcium oxalate monohydrate crystals. Urol Int 85: 237-241.
38. Khan SR, (2010) Nephrocalcinosis in animal models with and without stones. Urol Res 38: 429-438.
39. Khan SR, Johnson JM, Peck AB, Cornelius JG, Glenton PA, (2002) Expression of osteopontin in rat kidneys: induction during ethylene glycol induced calcium oxalate nephrolithiasis. J Urol 168: 1173v1181.
40. Grewal JS, Tsai JY, Khan SR, (2005) Oxalate-inducible AMBP gene and its regulatory mechanism in renal tubular epithelial cells. Biochem J 387: 609-616.
41. Iida S, Peck AB, Johnson-Tardieu J, Moriyama M, Glenton PA, et al. (1999) Temporal changes in mRNA expression for bikunin in the kidneys of rats during calcium oxalate nephrolithiasis. J Am Soc Nephrol 10: 986-996.
42. Umekawa T, Chegini N, Khan SR, (2002) Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells. Kidney Int 61: 105-112.
43. Umekawa T, Hatanaka Y, Kurita T, Khan SR, (2004) Effect of angiotensin II receptor blockage on osteopontin expression and calcium oxalate crystal deposition in rat kidneys. J Am Soc Nephrol 15: 635-644.
44. Marengo SR, Chen DH, Kaung HL, Resnick MI, Yang L, (2002) Decreased renal expression of the putative calcium oxalate inhibitor Tamm-Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis. J Urol 167: 2192-2197.
45. Mazzali M, Kipari T, Ophascharoensuk V, Wesson JA, Johnson R, et al. (2002) Osteopontin-a molecule for all seasons. QJM 95: 3-13.
46. Kleinman JG, Wesson JA, Hughes J, (2004) Osteopontin and calcium stone formation. Nephron Physiol 98: p43-47.
47. Schepers MS, van Ballegooijen ES, Bangma CH, Verkoelen CF, (2005) Oxalate is toxic to renal tubular cells only at supraphysiologic concentrations. Kidney Int 68: 1660-1669.
48. Shirotake S, Miyajima A, Kosaka T, Tanaka N, Kikuchi E, et al. (2012) Regulation of Monocyte Chemoattractant Protein-1 Through Angiotensin II Type 1 Receptor in Prostate Cancer. Am J Pathol 180: 1008-1016.
49. Takac I, Schroder K, Brandes RP, (2012) The Nox family of NADPH oxidases: friend or foe of the vascular system? Curr Hypertens Rep 14: 70-78.
50. Bedard K, Krause KH, (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87: 245-313.
51. Lassegue B, Sorescu D, Szocs K, Yin Q, Akers M, et al. (2001) Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 88: 888-894.
52. Sorescu GP, Song H, Tressel SL, Hwang J, Dikalov S, et al. (2004) Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase. Circ Res 95: 773-779.
53. Gorlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, et al. (2000) A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 87: 26-32.
54. Chamseddine AH, Miller FJ Jr, (2003) Gp91phox contributes to NADPH oxidase activity in aortic fibroblasts but not smooth muscle cells. Am J Physiol Heart Circ Physiol 285: H2284-2289.
55. Ago T, Kitazono T, Ooboshi H, Iyama T, Han YH, et al. (2004) Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 109: 227-233.
56. Ellmark SH, Dusting GJ, Fui MN, Guzzo-Pernell N, Drummond GR, (2005) The contribution of Nox4 to NADPH oxidase activity in mouse vascular smooth muscle. Cardiovasc Res 65: 495-504.
57. Hanna IR, Hilenski LL, Dikalova A, Taniyama Y, Dikalov S, et al. (2004) Functional association of nox1 with p22phox in vascular smooth muscle cells. Free Radic Biol Med 37: 1542-1549.
58. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, Griendling KK, (2004) Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24: 677-683.
59. Helmcke I, Heumuller S, Tikkanen R, Schroder K, Brandes RP, (2009) Identification of structural elements in Nox1 and Nox4 controlling localization and activity. Antioxid Redox Signal 11: 1279-1287.
60. Clempus RE, Sorescu D, Dikalova AE, Pounkova L, Jo P, et al. (2007) Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 27: 42-48.
61. Kuroda J, Nakagawa K, Yamasaki T, Nakamura K, Takeya R, et al. (2005) The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells. Genes Cells 10: 1139-1151.
62. Gill PS, Wilcox CS, (2006) NADPH oxidases in the kidney. Antioxid Redox Signal 8: 1597-1607.
63. Chabrashvili T, Tojo A, Onozato ML, Kitiyakara C, Quinn MT, et al. (2002) Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39: 269-274.
64. Banfi B, Maturana A, Jaconi S, Arnaudeau S, Laforge T, et al. (2000) A mammalian H+ channel generated through alternative splicing of the NADPH oxidase homolog NOH-1. Science 287: 138-142.
65. Cheng G, Cao Z, Xu X, van Meir EG, Lambeth JD, (2001) Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269: 131-140.
66. Geiszt M, Kopp JB, Varnai P, Leto TL, (2000) Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci U S A 97: 8010-8014.
67. Shiose A, Kuroda J, Tsuruya K, Hirai M, Hirakata H, et al. (2001) A novel superoxide-producing NAD(P)H oxidase in kidney. J Biol Chem 276: 1417-1423.